Steris (STE): financials, SEC filings and peers
Steris (STE) is a health care equipment company in the Health Care sector of the S&P 500, headquartered in Dublin, Ireland.
It was founded in 1985 and joined the S&P 500 on December 23, 2019.
Its fiscal year ends in March, and its shares trade on the NYSE.
In its SEC filings it is classified as “Orthopedic, Prosthetic & Surgical Appliances & Supplies”.
Steris at a glance
- Revenue (12 months)
- $6.0B
- Revenue growth
- +8.4%
- Operating margin
- 18.9%
- Net income (12 months)
- $805M
- Free cash flow (12 months)
- $926M
- Cash
- $482M
- Debt
- $1.9B
- Diluted EPS (12 months)
- —
Twelve months to June 30, 2026, from the 10-Q filed August 7, 2026.
Latest twelve months
Over the twelve months to June 30, 2026, Steris reported revenue of $6.0 billion, up 8.4% from a year earlier.
Its operating margin was 18.9%, up 2.3 percentage points from a year earlier: for every $100 of sales, about $19 was left as operating profit.
Net income was $805 million (13.3% of revenue), 24.5% higher than a year earlier.
Operating cash flow was $1.3 billion and capital spending $363 million, leaving free cash flow of $926 million (15.3% of revenue).
At the end of the period it held $482 million in cash and $1.9 billion in debt, a net debt position of $1.4 billion.
Five-year trend
- Revenue went from $3.1 billion in fiscal 2021 to $5.9 billion in fiscal 2026, about 13.8% a year.
- Revenue has grown for 5 fiscal years in a row.
- Operating margin has been steady, around 18.6%.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $4.2B | $4.5B | $5.1B | $5.5B | $5.9B |
| Revenue growth | 35.9% | 7.4% | 13.3% | 6.2% | 8.7% |
| Operating margin | 11.3% | 17.4% | 16.3% | 15.9% | 18.6% |
| Net income | $244M | $107M | $378M | $615M | $782M |
| Free cash flow | $397M | $395M | $613M | $778M | $972M |
| Diluted EPS | $2.48 | $1.07 | $3.81 | $6.20 | $7.93 |
Fiscal years as reported in Steris’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 10-Q filed August 7, 2026 — quarterly report
- 8-K filed August 6, 2026 — Shareholder vote results
- 8-K/A filed August 6, 2026 — Executive or director change
- 8-K filed August 5, 2026 — Earnings results; Restructuring costs
- 10-K filed May 29, 2026 — annual report
- 8-K filed May 11, 2026 — Earnings results
- 8-K filed May 7, 2026 — Executive or director change; Regulation FD disclosure
- 8-K filed April 6, 2026 — Executive or director change
Companies like Steris
Other S&P 500 companies in Health Care Equipment:
- ABTAbbott LaboratoriesNorth Chicago, Illinois
- BAXBaxter InternationalDeerfield, Illinois
- BDXBecton DickinsonFranklin Lakes, New Jersey
- BSXBoston ScientificMarlborough, Massachusetts
- DXCMDexcomSan Diego, California
- EWEdwards LifesciencesIrvine, California
- GEHCGE HealthCareChicago, Illinois
- IDXXIdexx LaboratoriesWestbrook, Maine
More from Health Care
Questions about Steris
Is Steris's revenue growing?
Yes. Revenue for the twelve months to June 30, 2026 was $6.0 billion, up 8.4% from a year earlier, according to its SEC filings.
Is Steris profitable?
Yes. It earned $805 million in net income over the twelve months to June 30, 2026, a net margin of 13.3%.
Does Steris have more cash or more debt?
At June 30, 2026 it had $482 million in cash and $1.9 billion in debt, so more debt than cash.
When did Steris last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on August 7, 2026.
Which companies are similar to Steris?
In the S&P 500, Steris is grouped in Health Care Equipment within the Health Care sector. Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Dexcom (DXCM) are in the same group.
Understand the numbers
Source: Steris’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.